Pharma Nordic ApS: Financial statements 2020
CVR: 37842338
Source: annual report 2020, Danish Business Authority
01/10/2019 – 30/09/2020
Pharma Nordic ApS (CVR 37842338) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 26,100 and a net result of DKK -139,981. The profit margin was -536.3%. Equity in the 2020 report amounted to DKK 724,906. The solvency ratio was 44.4%.
- Revenue
- DKK 26,100
- Gross Profit
- DKK -101,652
- Profit/Loss
- DKK -139,981
- Equity
- DKK 724,906
- Total Assets
- DKK 1,633,593
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 26 t. | -102 t. | -140 t. | 725 t. | - |
| 2018 | 42 t. | -42 t. | -64 t. | 644 t. | - |
Official annual report
How creditworthy is Pharma Nordic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Pharma Nordic ApS
Pharma Nordic ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2016. The company is registered under the industry Anden udlejning af boliger. The management consists of Niels Skovmand Juhl. The company is owned by Niels Skovmand Juhl, Christopher Skovmand Møller Juhl and Stephanie Skovmand Møller Juhl. According to the 2021 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -5,137 the year before. Equity in the 2025 report amounted to DKK -23,687.